[en] Abstract
Pulmonary hypertension (PH), defined by increased pressure within the pulmonary vasculature, is a hemodynamic and pathophysiologic state present in a wide variety of cardiovascular, respiratory, and systemic diseases. The purpose of this consensus statement is
to provide a multidisciplinary approach to guidelines for the diagnosis, classification, treatment, and monitoring of PH in dogs. Comprehensive evaluation including consideration of signalment, clinical signs, echocardiographic parameters, and results of other diagnostic tests supports the diagnosis of PH and allows identification of associated
underlying conditions. Dogs with PH can be classified into the following 6 groups: group
1, pulmonary arterial hypertension; group 2, left heart disease; group 3, respiratory disease/hypoxia; group 4, pulmonary emboli/pulmonary thrombi/pulmonary thromboemboli;
group 5, parasitic disease (Dirofilaria and Angiostrongylus); and group 6, disorders that are
multifactorial or with unclear mechanisms. The approach to treatment of PH focuses on
strategies to decrease the risk of progression, complications, or both, recommendations to
target underlying diseases or factors contributing to PH, and PH-specific treatments. Dogs
with PH should be monitored for improvement, static condition, or progression, and any
identified underlying disorder should be addressed and monitored simultaneously.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Reinero, Carol; College of Veterinary Medicine, University of Missouri, Columbia, Missouri > Department of Veterinary Medicine and Surgery
Visser, Lance C.; School of Veterinary Medicine, University of California, Davis, Davis, California > Department of Medicine and Epidemiology
Kellihan, Heidi B.; School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin > Department of Medical Sciences
Masseau, Isabelle; Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Quebec, Canada > Department of Sciences Cliniques
Rozanski, Elizabeth; Cummings School of Veterinary Medicine, Tufts University, Medford, Massachusetts > Department of Clinical Sciences
Clercx, Cécile ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
williams, Kurt; College of Veterinary Medicine, Michigan State University, East Lansing, Michigan > Department of Pathobiology and Diagnostic Investigation
Abbott, Jonathan; College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee > Department of Small Animal Clinical Sciences
Borgarelli, Michele; Virginia Maryland College of Veterinary Medicine, Blacksburg, Virginia > Department of Small Animal Clinical Sciences
Scansen, Brian A.; Colorado State University, Fort Collins, Colorado > Department of Clinical Sciences
Language :
English
Title :
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs
Thangaratinam S, Redman CWE. The Delphi technique. Obstet Gynaecol. 2005;7:120-125.
Hsu CC, Sandford BA. The Delphi technique: making sense of consensus. Pract Assess Res Eval. 2007;12:1-7.
Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D42-D50.
Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53:pii:13993003.01913-2018. https://doi.org/10.1183/13993003.01913-2018.
Vachiery JL, Adir Y, Barbera JA, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013;62:D100-D108.
Guazzi M, Naeije R. Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives. J Am Coll Cardiol. 2017;69:1718-1734.
Kellihan HB, Stepien RL. Pulmonary hypertension in canine degenerative mitral valve disease. J Vet Cardiol. 2012;14:149-164.
Soydan LC, Kellihan HB, Bates ML, et al. Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension. J Vet Cardiol. 2015;17:13-24.
Abbott JA, Gentile-Solomon JM. Measurement variation and repeatability of echocardiographic variables used to estimate pulmonary artery pressure in dogs. J Vet Intern Med. 2017;31:1622-1628.
Rhinehart JD, Schober KE, Scansen BA, Yildiz V, Bonagura JD. Effect of body position, exercise, and sedation on estimation of pulmonary artery pressure in dogs with degenerative atrioventricular valve disease. J Vet Intern Med. 2017;31:1611-1621.
Augustine DX, Coates-Bradshaw LD, Willis J, et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res Pract. 2018;5:G11-g24.
Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67-119.
Serres FJ, Chetboul V, Tissier R, et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005). J Am Vet Med Assoc. 2006;229:1772-1778.
Studley J, Tighe DA, Joelson JM, Flack JE III. The hemodynamic signs of constrictive pericarditis can be mimicked by tricuspid regurgitation. Cardiol Rev. 2003;11:320-326.
Ge Z, Zhang Y, Ji X, et al. Pulmonary artery diastolic pressure: a simultaneous Doppler echocardiography and catheterization study. Clin Cardiol. 1992;15:818-824.
Masuyama T, Kodama K, Kitabatake A, Sato H, Nanto S, Inoue M. Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure. Circulation. 1986;74:484-492.
Visser LC, Im MK, Johnson LR, Stern JA. Diagnostic value of right pulmonary artery distensibility index in dogs with pulmonary hypertension: comparison with Doppler echocardiographic estimates of pulmonary arterial pressure. J Vet Intern Med. 2016;30:543-552.
Serres F, Chetboul V, Gouni V, Tissier R, Sampedrano CC, Pouchelon JL. Diagnostic value of echo-Doppler and tissue Doppler imaging in dogs with pulmonary arterial hypertension. J Vet Intern Med. 2007;21:1280-1289.
Gentile-Solomon JM, Abbott JA. Conventional echocardiographic assessment of the canine right heart: reference intervals and repeatability. J Vet Cardiol. 2016;18:234-247.
Vezzosi T, Domenech O, Iacona M, et al. Echocardiographic evaluation of the right atrial area index in dogs with pulmonary hypertension. J Vet Intern Med. 2018;32:42-47.
Vezzosi T, Domenech O, Costa G, et al. Echocardiographic evaluation of the right ventricular dimension and systolic function in dogs with pulmonary hypertension. J Vet Intern Med. 2018;32:1541-1548.
Venco L, Mihaylova L, Boon JA. Right pulmonary artery Distensibility index (RPAD index). A field study of an echocardiographic method to detect early development of pulmonary hypertension and its severity even in the absence of regurgitant jets for Doppler evaluation in heartworm-infected dogs. Vet Parasitol. 2014;206:60-66.
Caivano D, Dickson D, Pariaut R, Stillman M, Rishniw M. Tricuspid annular plane systolic excursion-to-aortic ratio provides a bodyweight-independent measure of right ventricular systolic function in dogs. J Vet Cardiol. 2018;20:79-91.
Caivano D, Rishniw M, Birettoni F, et al. Right ventricular outflow tract fractional shortening: an echocardiographic index of right ventricular systolic function in dogs with pulmonary hypertension. J Vet Cardiol. 2018;20:354-363.
Pariaut R, Saelinger C, Strickland KN, Beaufrère H, Reynolds CA, Vila J. Tricuspid annular plane systolic excursion (TAPSE) in dogs: reference values and impact of pulmonary hypertension. J Vet Intern Med. 2012;26:1148-1154.
Visser LC, Scansen BA, Brown NV, Schober KE, Bonagura JD. Echocardiographic assessment of right ventricular systolic function in conscious healthy dogs following a single dose of pimobendan versus atenolol. J Vet Cardiol. 2015;17:161-172.
Visser LC, Sintov DJ, Oldach MS. Evaluation of tricuspid annular plane systolic excursion measured by two-dimensional echocardiography in healthy dogs: repeatability, reference intervals, and comparison with M-mode assessment. J Vet Cardiol. 2018;20:165-174.
Schober KE, Baade H. Doppler echocardiographic prediction of pulmonary hypertension in West Highland white terriers with chronic pulmonary disease. J Vet Intern Med. 2006;20:912-920.
Kyranis SJ, Latona J, Platts D, et al. Improving the echocardiographic assessment of pulmonary pressure using the tricuspid regurgitant signal-the "chin" vs the "beard". Echocardiography. 2018;35:1085-1096.
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native Valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303-371.
Amsallem M, Sternbach JM, Adigopula S, et al. Addressing the controversy of estimating pulmonary arterial pressure by echocardiography. J Am Soc Echocardiogr. 2016;29:93-102.
Constantinescu GM. Illustrated Veterinary Anatomical Nomenclature. New York: Thieme Medical Publishers; 2018.
Visser LC. Right ventricular function: imaging techniques. Vet Clin North Am Small Anim Pract. 2017;47:989-1003.
Tidholm A, Hoglund K, Haggstrom J, et al. Diagnostic value of selected echocardiographic variables to identify pulmonary hypertension in dogs with myxomatous mitral valve disease. J Vet Intern Med. 2015;29:1510-1517.
Johnson LR, Boon J, Orton EC. Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992–1996. J Vet Intern Med. 1999;13:440-447.
Zabka TS, Campbell FE, Wilson DW. Pulmonary arteriopathy and idiopathic pulmonary arterial hypertension in six dogs. Vet Pathol. 2006;43:510-522.
Glaus TM, Soldati G, Maurer R, et al. Clinical and pathological characterisation of primary pulmonary hypertension in a dog. Vet Rec. 2004;154:786-789.
Iregui C, Ávila J, Ospina JC, Doncel B, Caicedo J, Verjan N. Idiopathic pulmonary hypertension in a dog: involvement of cardiac and renal microvasculature. J Comp Pathol. 2015;152:79-80.
Moon HS, Lee SG, Choi R, et al. Primary pulmonary hypertension in a maltese dog. J Vet Clin. 2007;24:613-617.
Kellihan HB, Waller KR, Pinkos A, et al. Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005-2014. J Vet Cardiol. 2015;17:182-191.
Guglielmini C, Civitella C, Diana A, di Tommaso M, Cipone M, Luciani A. Serum cardiac troponin I concentration in dogs with precapillary and postcapillary pulmonary hypertension. J Vet Intern Med. 2010;24:145-152.
Bach JF, Rozanski EA, MacGregor J, Betkowski JM, Rush JE. Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. J Vet Intern Med. 2006;20:1132-1135.
Swann JW, Sudunagunta S, Covey HL, English K, Hendricks A, Connolly DJ. Evaluation of red cell distribution width in dogs with pulmonary hypertension. J Vet Cardiol. 2014;16:227-235.
Serres F, Nicolle AP, Tissier R, Gouni V, Pouchelon JL, Chetboul V. Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog. J Vet Med A. 2006;53:129-133.
Toyoshima Y, Kanemoto I, Arai S, et al. A case of long-term sildenafil therapy in a young dog with pulmonary hypertension. J Vet Med Sci. 2007;69:1073-1075.
Kolm US, Amberger CN, Boujon CE, Lombard CW. Plexogenic pulmonary arteriopathy in a Pembroke welsh corgi. J Small Anim Pract. 2004;45:461-466.
Oswald GP, Orton EC. Patent ductus arteriosus and pulmonary hypertension in related Pembroke welsh corgis. J Am Vet Med Assoc. 1993;202:761-764.
Barman SA, Isales CM. Fenfluramine potentiates canine pulmonary vasoreactivity to endothelin-1. Pulm Pharmacol Ther. 1998;11:183-187.
Naeije R, Maggiorini M, Delcroix M, Leeman M, Mélot C. Effects of chronic dexfenfluramine treatment on pulmonary hemodynamics in dogs. Am J Respir Crit Care Med. 1996;154:1347-1350.
Paradies P, Spagnolo PP, Amato ME, Pulpito D, Sasanelli M. Doppler echocardiographic evidence of pulmonary hypertension in dogs: a retrospective clinical investigation. Vet Res Commun. 2014;38:63-71.
Pyle RL, Abbott J, MacLean H. Pulmonary hypertension and cardiovascular sequelae in 54 dogs. Intern J Appl Res Vet Med. 2004;2:99-109.
Kellum HB, Stepien RL. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. J Vet Intern Med. 2007;21:1258-1264.
Galie N, Manes A, Palazzini M, et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome. Drugs. 2008;68:1049-1066.
Côté E, Ettinger SJ. Long-term clinical management of right-to-left ("reversed") patent ductus arteriosus in 3 dogs. J Vet Intern Med. 2001;15:39-42.
Seibert RL, Maisenbacher HW, Prosek R, et al. Successful closure of left-to-right patent ductus arteriosus in three dogs with concurrent pulmonary hypertension. J Vet Cardiol. 2010;12:67-73.
Ackerman D. A right-to-left shunting patent ductus arteriosus with secondary pulmonary hypertension in a dog. Vet Radiol Ultrasound. 1992;33:141-144.
Ahn S-T, Kim M-J, Yoon W-K, Suh SI, Hyun C. Right to left atrial septum defect compounded with patent ductus arteriosus in a Maltese dog. J Vet Clin. 2017;34:90-94.
Barst RJ. Clinical management of patients with pulmonary hypertension. Moss and Adams' Heart Diseases in Infants, Children and Adolescents. Philadelphia, PA: Lippincott Williams and Wilkins, 2014:1-13.
Beghetti M, Galiè N. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;53:733-740.
Boutet BG, Saunders AB, Gordon SG. Clinical characteristics of adult dogs more than 5 years of age at presentation for patent ductus arteriosus. J Vet Intern Med. 2017;31:685-690.
Campbell FE, Thomas W, Miller SJ, et al. Immediate and late outcomes of transarterial coil occlusion of patent ductus arteriosus in dogs. J Vet Intern Med. 2006;20:83-96.
Ferasin L, Rizzo F, Darke PGG. Original investigation of right-to-left shunting patent ductus arteriosus in an Irish setter puppy. Vet J. 2007;173:443-448.
Gavaghan BJ, Lapointe JM, Thomas WP. Acute onset of pulmonary necrotising arteritis in a dog with a left-to-right patent ductus arteriosus. Aust Vet J. 1998;76:786-791.
Goya S, Kanno N, Teshima K, et al. Surgery for partial atrioventricular septal defect with pulmonary hypertension in an adult dog. J Vet Med Sci. 2018;80:1183-1189.
Iizuka T, Hoshi K, Ohmaki M, et al. Surgical ligation of patent ductus arterisus suspected severe pulmonary hypertension in a dog. Adv Anim Cardiol. 2009;42:43-48.
Kellihan HB, Mackie BA, Stepien RL. NT-proBNP, NT-proANP and cTnI concentrations in dogs with pre-capillary pulmonary hypertension. J Vet Cardiol. 2011;13:171-182.
Markovic LE, Kellihan HB, Roldán-Alzate A, Drees R, Bjorling DE, Francois CJ. Advanced multimodality imaging of an anomalous vessel between the ascending aorta and main pulmonary artery in a dog. J Vet Cardiol. 2014;16:59-65.
Nelson AW. Aorticopulmonary window in a dog. J Am Vet Med Assoc. 1986;188(9):1055-1058.
Patterson DF, Pyle RL, Buchanan JW, Trautvetter E, Abt DA. Hereditary patent ductus arteriosus and its sequelae in the dog. Circ Res. 1971;29:1-13.
Pyle RL, Park RD, Alexander AF, Hill BL. Patent ductus arteriosus with pulmonary hypertension in the dog. J Am Vet Med Assoc. 1981;178:565-571.
Turk JR, Miller LM, Miller JB, et al. Necrotizing pulmonary arteritis in a dog with patent ductus arteriosus. J Small Anim Pract. 1981;22:603-608.
Ware WA, Bonagura JD. Multiple congenital cardiac anomalies and Eisenmenger's syndrome in a dog. Compend Contin Educ Pract Vet. 1988;10:932-949.
Fujii Y, Ishikawa T, Sunahara H, et al. Partial anomalous pulmonary venous connection in 2 miniature schnauzers. J Vet Intern Med. 2014;28:678-681.
Hilwig RW, Bishop SP. Anomalous pulmonary venous return in a great Dane. Am J Vet Res. 1975;36:229-233.
Hogan DF, Green HW 3rd, Van Alstine WG. Total anomalous pulmonary venous drainage in a dog. J Vet Intern Med. 2002;16:303-308.
Pumarola M, Brevik L, Badiola J, Vargas A, Domingo M, Ferrer L. Canine leishmaniasis associated with systemic vasculitis in two dogs. J Comp Pathol. 1991;105:279-286.
Russell NJ, Irwin PJ, Hopper BJ, Olivry T, Nicholls PK. Acute necrotising pulmonary vasculitis and pulmonary hypertension in a juvenile dog. J Small Anim Pract. 2008;49:349-355.
Turk M, Turk JR, Rantanen NW, et al. Necrotizing pulmonary arteritis in a dog with peritoneo-pericardial diaphragmatic hernia. J Small Anim Pract. 1984;25:25-30.
Faunt KK, Turk JR, Cohn LA, et al. Isolated right-ventricular hypertrophy associated with severe pulmonary vascular apolipoprotein A1-derived amyloidosis in a dog. J Am Anim Hosp Assoc. 1998;34:35-37.
Reinero CR, Jutkowitz LA, Nelson N, Masseau I, Jennings S, Williams K. Clinical features of canine pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. J Vet Intern Med. 2019;33:114-123.
Williams K, Andrie K, Cartoceti A, et al. Pulmonary veno-occlusive disease: a newly recognized cause of severe pulmonary hypertension in dogs. Vet Pathol. 2016;53:813-822.
Borgarelli M, Abbott J, Braz-Ruivo L, et al. Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease. J Vet Intern Med. 2015;29:569-574.
Atkinson KJ, Fine DM, Thombs LA, Gorelick JJ, Durham HE. Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs. J Vet Intern Med. 2009;23:1190-1196.
Brown AJ, Davison E, Sleeper MM. Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs. J Vet Intern Med. 2010;24:850-854.
Mazzotta E, Guglielmini C, Menciotti G, et al. Red blood cell distribution width, hematology, and serum biochemistry in dogs with echocardiographically estimated precapillary and postcapillary pulmonary arterial hypertension. J Vet Intern Med. 2016;30:1806-1815.
Poser H, Berlanda M, Monacolli M, Contiero B, Coltro A, Guglielmini C. Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension. J Vet Cardiol. 2017;19:228-239.
Baron Toaldo M, Poser H, Menciotti G, et al. Utility of tissue Doppler imaging in the echocardiographic evaluation of left and right ventricular function in dogs with Myxomatous mitral valve disease with or without pulmonary hypertension. J Vet Intern Med. 2016;30:697-705.
Lee Y, Choi W, Lee D, et al. Correlation between caudal pulmonary artery diameter to body surface area ratio and echocardiography-estimated systolic pulmonary arterial pressure in dogs. J Vet Sci. 2016;17:243-251.
Mikawa S, Miyagawa Y, Toda N, et al. Predictive model for the detection of pulmonary hypertension in dogs with myxomatous mitral valve disease. J Vet Med Sci. 2015;77:7-13.
Lehmkuhl LB, Ware WA, Bonagura JD. Mitral stenosis in 15 dogs. J Vet Intern Med. 1994;8:2-17.
Jaffey JA, Wiggen K, Leach SB, et al. Pulmonary hypertension secondary to respiratory disease and/or hypoxia in dogs: clinical features, diagnostic testing and survival. Vet J. 2019;251:105347. https://doi.org/10.1016/j.tvjl.2019105347.
Roels E, Merveille A-C, Moyse E, et al. Diagnostic value of the pulmonary vein to right pulmonary artery ratio in dogs with pulmonary hypertension of pre-capillary origin. J Vet Cardiol. 2019;24:84-94.
Bottero E, Bellino C, De Lorenzi D, et al. Clinical evaluation and endoscopic classification of bronchomalacia in dogs. J Vet Intern Med. 2013;27:840-846.
Reinero C. Interstitial lung diseases in dogs and cats part I: the idiopathic interstitial pneumonias. Vet J. 2019;243:48-54.
Reinero C. Interstitial lung diseases in dogs and cats part II: known cause and other discrete forms. Vet J. 2019;243:55-64.
Norris CR, Griffey SM, Walsh P. Use of keyhole lung biopsy for diagnosis of interstitial lung diseases in dogs and cats: 13 cases (1998-2001). J Am Vet Med Assoc. 2002;221:1453-1459.
Phillips S, Barr S, Dykes N, et al. Bronchiolitis obliterans with organizing pneumonia in a dog. J Vet Intern Med. 2000;14:204-207.
Cummings AC, Spaulding KA, Scott KD, et al. Imaging diagnosis—pulmonary alveolar proteinosis in a dog. Vet Radiol Ultrasound. 2013;54:634-637.
Koster LS, Kirberger RM. A syndrome of severe idiopathic pulmonary parenchymal disease with pulmonary hypertension in Pekingese. Vet Med (Auck). 2016;7:19-31.
Morita T, Nakamura K, Osuga T, et al. Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke welsh corgi. J Vet Med Sci. 2018;80:939-944.
Mesquita L, Lam R, Lamb CR, McConnell JF. Computed tomographic findings in 15 dogs with eosinophilic bronchopneumopathy. Vet Radiol Ultrasound. 2015;56:33-39.
Okine AAK, Chapman S, Hostutler RA, Livingston R. Diagnosis of pneumocystis pneumonia in a 2-year-old King Charles cavalier spaniel using the polymerase chain reaction. Vet Clin Pathol. 2018;47:146-149.
Schiborra F, Scudder CJ, Littler RM, Lamb CR, McConnell JF, Maddox TW. CT findings in pneumocystis carinii pneumonia in five dogs. J Small Anim Pract. 2018;59:508-513.
Locatelli C, Stefanello D, Riscazzi G, et al. Pulmonary hypertension associated with Ehrlichia canis infection in a dog. Vet Rec. 2012;170:676.
Toom ML, Dobak TP, Broens EM, et al. Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog. Acta Vet Scand. 2016;58:46.
Bertazzolo W, Zuliani D, Pogliani E, Caniatti M, Bussadori C. Diffuse bronchiolo-alveolar carcinoma in a dog. J Small Anim Pract. 2002;43:265-268.
Ding X, Yu C, Liu Y, et al. Chronic obstructive sleep apnea accelerates pulmonary remodeling via TGF-beta/miR-185/CoLA1 signaling in a canine model. Oncotarget. 2016;7:57545-57555.
Tarasiuk A, Chen L, Scharf SM. Effects of periodic obstructive apnoeas on superior and inferior venous return in dogs. Acta Physiol Scand. 1997;161:187-194.
Tai TC, Huang HP. Echocardiographic assessment of right heart indices in dogs with elevated pulmonary artery pressure associated with chronic respiratory disorders, heartworm disease, and chronic degenerative mitral valvular disease. Vet Med Czech. 2013;58:613-620.
Glaus TM, Hassig M, Baumgartner C, et al. Pulmonary hypertension induced in dogs by hypoxia at different high-altitude levels. Vet Res Commun. 2003;27:661-670.
Glaus TM, Hauser K, Hassig M, Lipp B, Reusch CE. Non-invasive measurement of the cardiovascular effects of chronic hypoxaemia on dogs living at moderately high altitude. Vet Rec. 2003;152:800-803.
Glaus TM, Tomsa K, Hassig M, Reusch C. Echocardiographic changes induced by moderate to marked hypobaric hypoxia in dogs. Vet Radiol Ultrasound. 2004;45:233-237.
Gomez A, Unruh H, Mink SN. Altered left ventricular chamber stiffness and isovolumic relaxation in dogs with chronic pulmonary hypertension caused by emphysema. Circulation. 1993;87:247-260.
Kocaturk M, Salci H, Yilmaz Z, et al. Pre- and post-operative cardiac evaluation of dogs undergoing lobectomy and pneumonectomy. J Vet Sci. 2010;11:257-264.
Goggs R, Chan DL, Benigni L, Hirst C, Kellett-Gregory L, Fuentes VL. Comparison of computed tomography pulmonary angiography and point-of-care tests for pulmonary thromboembolism diagnosis in dogs. J Small Anim Pract. 2014;55:190-197.
Klein MK, Dow SW, Rosychuk RA. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987). J Am Vet Med Assoc. 1989;195:246-250.
Burns MG, Kelly AB, Hornof WJ, Howerth EW. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Med Assoc. 1981;178:388-393.
Mitchell CW. The imaging diagnosis of pulmonary thromboembolism. Can Vet J. 2009;50:199-202.
Baines EA, Watson PJ, Stidworthy MF, Herrtage ME. Gross pulmonary thrombosis in a greyhound. J Small Anim Pract. 2001;42:448-452.
Jacinto AML, Ridyard AE, Aroch I, et al. Thromboembolism in dogs with protein-losing enteropathy with non-neoplastic chronic small intestinal disease. J Am Anim Hosp Assoc. 2017;53:185-192.
Preston AR, Sullivan LA. Dislodgement of a right atrial thrombus and subsequent pulmonary thromboembolism following tracheal stent deployment in a dog. J Vet Emerg Crit Care. 2016;26:809-814.
Bellofiore A, Henningsen J, Lepak CG, et al. A novel in vivo approach to assess radial and axial distensibility of large and intermediate pulmonary artery branches. J Biomech Eng. 2015;137:044501.
Bellofiore A, Roldan-Alzate A, Besse M, et al. Impact of acute pulmonary embolization on arterial stiffening and right ventricular function in dogs. Ann Biomed Eng. 2013;41:195-204.
Tian L, Kellihan HB, Henningsen J, et al. Pulmonary artery relative area change is inversely related to ex vivo measured arterial elastic modulus in the canine model of acute pulmonary embolization. J Biomech. 2014;47:2904-2910.
Roldan-Alzate A, Frydrychowicz A, Johnson KM, et al. Non-invasive assessment of cardiac function and pulmonary vascular resistance in an canine model of acute thromboembolic pulmonary hypertension using 4D flow cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:23.
Golob MJ, Tabima DM, Wolf GD, et al. Pulmonary arterial strain- and remodeling-induced stiffening are differentiated in a chronic model of pulmonary hypertension. J Biomech. 2017;55:92-98.
Johnson LR. Diagnosis of pulmonary hypertension. Clin Tech Small Anim Pract. 1999;14:231-236.
Hirano Y, Kitagawa H, Sasaki Y. Relationship between pulmonary arterial pressure and pulmonary thromboembolism associated with dead worms in canine heartworm disease. J Vet Med Sci. 1992;54:897-904.
Rawlings CA. Cardiopulmonary function in the dog with Dirofilaria immitis infection: during infection and after treatment. Am J Vet Res. 1980;41:319-325.
Sasaki Y, Kitagawa H, Hirano Y. Relationship between pulmonary arterial pressure and lesions in the pulmonary arteries and parenchyma, and cardiac valves in canine dirofilariasis. J Vet Med Sci. 1992;54:739-744.
Serrano-Parreno B, Carreton E, Caro-Vadillo A, et al. Pulmonary hypertension in dogs with heartworm before and after the adulticide protocol recommended by the American heartworm society. Vet Parasitol. 2017;236:34-37.
Wallace CR, Hamilton WF. Study of spontaneous congestive heart failure in the dog. Circ Res. 1962;11:301-314.
Adcock JL. Pulmonary arterial lesions in canine dirofilariasis. Am J Vet Res. 1961;22:655-662.
Hennigar GR, Ferguson RW. Pulmonary vascular sclerosis as a result of Dirofilaria immitis infection in dogs. J Am Vet Med Assoc. 1957;131:336-340.
Hirth RS, Huizinga HW, Nielsen SW. Dirofilariasis in Connecticut dogs. J Am Vet Med Assoc. 1966;148:1508-1516.
Matos JM, Schnyder M, Bektas R, et al. Recruitment of arteriovenous pulmonary shunts may attenuate the development of pulmonary hypertension in dogs experimentally infected with Angiostrongylus vasorum. J Vet Cardiol. 2012;14:313-322.
Porter WB. Chronic cor pulmonale in dogs with Difilaria immitis (heart worms) infestation. Trans Assoc Am Physicians. 1951;64:328-334.
Prestwood AK, Greene CE, Mafaffey EA, et al. Experimental canine angiostrongylosis. I. Pathologic manifestations. J Am Anim Hosp Assoc. 1981;17:491-497.
Rawlings CA. Pulmonary vascular response of dogs with heartworm disease. Can J Comp Med. 1978;42:452-459.
Serrano-Parreno B, Carreton E, Caro-Vadillo A, et al. Evaluation of pulmonary hypertension and clinical status in dogs with heartworm by right pulmonary artery Distensibility index and other echocardiographic parameters. Parasit Vectors. 2017;10:106.
Tulloch GS, Pacheco G, Casey HW, Bills WE, Davis I, Anderson RA. Prepatent clinical, pathologic, and serologic changes in dogs infected with Dirofilaria immitis and treated with diethylcarbamazine. Am J Vet Res. 1970;31:437-448.
Uehara Y. An attempt to estimate the pulmonary artery pressure in dogs by means of pulsed Doppler echocardiography. J Vet Med Sci. 1993;55:307-312.
Calvert CA, Rawlings CA. Pulmonary manifestations of heartworm disease. Vet Clin North Am Small Anim Pract. 1985;15:991-1009.
Canonne AM, Roels E, Caron Y, et al. Detection of Angiostrongylus vasorum by quantitative PCR in bronchoalveolar lavage fluid in Belgian dogs. J Small Anim Pract. 2016;57:130-134.
Confer AW, Qualls CW Jr, MacWilliams PS, et al. Four cases of pulmonary nodular eosinophilic granulomatosis in dogs. Cornell Vet. 1983;73:41-51.
Novo Matos J, Malbon A, Dennler M, Glaus T. Intrapulmonary arteriovenous anastomoses in dogs with severe angiostrongylus vasorum infection: clinical, radiographic, and echocardiographic evaluation. J Vet Cardiol. 2016;18:110-124.
Rawlings CA, Raynaud JP, Lewis RE, Duncan JR. Pulmonary thromboembolism and hypertension after thiacetarsamide vs melarsomine dihydrochloride treatment of Dirofilaria immitis infection in dogs. Am J Vet Res. 1993;54:920-925.
Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34-D41.
Tessier-Vetzel D, Tissier R, Chetboul V, et al. Diagnostic and prognostic value of endothelin-1 plasma concentrations in dogs with heart and respiratory disorders. Vet Rec. 2006;158:783-788.
Rubin JA, Holt DE, Reetz JA, Clarke DL. Signalment, clinical presentation, concurrent diseases, and diagnostic findings in 28 dogs with dynamic pharyngeal collapse (2008-2013). J Vet Intern Med. 2015;29:815-821.
Hendricks JC, Kline LR, Kovalski RJ, O'Brien JA, Morrison AR, Pack AI THe English bulldog: a natural model of sleep-disordered breathing. J Appl Physiol 1987;63:1344–1350.
Chiavegato D, Borgarelli M, D'Agnolo G, et al. Pulmonary hypertension in dogs with mitral regurgitation attributable to myxomatous valve disease. Vet Radiol Ultrasound. 2009;50:253-258.
Campbell FE. Cardiac effects of pulmonary disease. Vet Clin North Am Small Anim Pract. 2007;37:949-962. vii.
Kellihan HB, Stepien RL. Pulmonary hypertension in dogs: diagnosis and therapy. Vet Clin North Am Small Anim Pract. 2010;40:623-641.
Ohad DG, Lenchner I, Bdolah-Abram T, Segev G. A loud right-apical systolic murmur is associated with the diagnosis of secondary pulmonary arterial hypertension: retrospective analysis of data from 201 consecutive client-owned dogs (2006-2007). Vet J. 2013;198:690-695.
Carey SA. Clinical evaluation of the respiratory tract. In: Ettinger SJ, Feldman E, Cote E, eds. Textbook of Veterinary Internal Medicine. St. Louis, MO: Elsevier, Inc; 2017:1083-1093.
Adamama-Moraitou KK, Pardali D, Day MJ, et al. Canine bronchomalacia: a clinicopathological study of 18 cases diagnosed by endoscopy. Vet J. 2012;191:261-266.
Clercx C, Fastres A, Roels E. Idiopathic pulmonary fibrosis in West Highland white terriers: an update. Vet J. 2018;242:53-58.
Borgarelli M, Zini E, D'Agnolo G, et al. Comparison of primary mitral valve disease in German shepherd dogs and in small breeds. J Vet Cardiol. 2004;6:27-34.
Simonneau G, Galiè N, Rubin LJ. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:S5-S12.
Keene BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127-1140.
Borgeat K, Sudunagunta S, Kaye B, Stern J, Luis Fuentes V, Connolly DJ. Retrospective evaluation of moderate-to-severe pulmonary hypertension in dogs naturally infected with Angiostrongylus vasorum. J Small Anim Pract. 2015;56:196-202.
Adams DS, Marolf AJ, Valdes-Martinez A, et al. Associations between thoracic radiographic changes and severity of pulmonary arterial hypertension diagnosed in 60 dogs via Doppler echocardiography: a retrospective study. Vet Radiol Ultrasound. 2017;58:454-462.
Vientos-Plotts A, Wiggen KE, Lisciandro GR, et al. The utility of point-of care ultrasound right-sided cardiac markers as a screening test for moderate to severe pulmonary hypertension in dogs. Vet J. 2019;250:6-13.
Nelson CT, McCall JW, Jones S, et al. Current Canine Guidelines for the Prevention, Diagnosis, and Management of Heartworm (Dirofilaria Immitis) Infection in Dogs. Wilmington, DE: American Heartworm Society; 2018.
de Laforcade A. Diseases associated with thrombosis. Top Companion Anim Med. 2012;27:59-64.
Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med. 1999;13:338-345.
LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc. 1990;197:1368-1372.
Goggs R, Blais MC, Brainard BM, et al. American College of Veterinary Emergency and Critical Care (ACVECC) consensus on the rational use of Antithrombotics in veterinary critical care (CURATIVE) guidelines: small animal. J Vet Emergency Crit Care. 2019;29:12-36.
Sutherland-Smith J, Hankin EJ, Cunningham SM, Sato AF, Barton BA. Comparison of a computed tomographic pulmonary trunk to aorta diameter ratio with echocardiographic indices of pulmonary hypertension in dogs. Vet Radiol Ultrasound. 2018;59:18-26.
Seiler GS, Nolan TJ, Withnall E, et al. Computed tomographic changes associated with the prepatent and early patent phase of dirofilariasis in an experimentally infected dog. Vet Radiol Ultrasound. 2010;51:136-140.
Masseau I, Reinero CR. Thoracic computed tomographic interpretation for clinicians to aid in the diagnosis of dogs and cats with respiratory disease. Vet J. 2019;253:105388. https://doi.org/10.1016/j.tvjl.2019.105388.
LeBlanc NL, Scollan KF. Quantification of right ventricular volume measured by use of real-time three-dimensional echocardiography and electrocardiography-gated 64-slice multidetector computed tomography in healthy dogs. Am J Vet Res. 2018;79:404-410.
Sieslack AK, Dziallas P, Nolte I, Wefstaedt P, Hungerbühler SO. Quantification of right ventricular volume in dogs: a comparative study between three-dimensional echocardiography and computed tomography with the reference method magnetic resonance imaging. BMC Vet Res. 2014;10:242.
Maboni G, Seguel M, Lorton A, Berghaus R, Sanchez S. Canine infectious respiratory disease: new insights into the etiology and epidemiology of associated pathogens. PLoS One. 2019;14:e0215817.
Farber HW, Badesch DB, Benza RL, et al. Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL. J Heart Lung Transplant. 2018;37:948-955.
Moore KW, Stepien RL. Hydroxyurea for treatment of polycythemia secondary to right-to-left shunting patent ductus arteriosus in 4 dogs. J Vet Intern Med. 2001;15:418-421.
Atkins CE, Keene BW, Brown WA, et al. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc. 2007;231:1061-1069.
Boswood A, Haggstrom J, Gordon SG, et al. Effect of Pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC study-a randomized clinical trial. J Vet Intern Med. 2016;30:1765-1779.
Summerfield NJ, Boswood A, O'Grady MR, et al. Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman pinschers with preclinical dilated cardiomyopathy (the PROTECT study). J Vet Intern Med. 2012;26:1337-1349.
Maggiore AD. Tracheal and airway collapse in dogs. Vet Clin North Am Small Anim Pract. 2014;44:117-127.
Kauppert CA, Dvorak I, Kollert F, et al. Pulmonary hypertension in obesity-hypoventilation syndrome. Respir Med. 2013;107:2061-2070.
Warricker F, Islam Z, Shah BN. Lesson of the month 1: obesity hypoventilation (Pickwickian) syndrome: a reversible cause of severe pulmonary hypertension. Clin Med (Lond). 2017;17:578-581.
Rozanski E. Canine chronic bronchitis. Vet Clin North Am Small Anim Pract. 2014;44:107-116.
Bexfield NH, Foale RD, Davison LJ, Watson PJ, Skelly BJ, Herrtage ME. Management of 13 cases of canine respiratory disease using inhaled corticosteroids. J Small Anim Pract. 2006;47:377-382.
Canonne AM, Bolen G, Peeters D, Billen F, Clercx C. Long-term follow-up in dogs with idiopathic eosinophilic bronchopneumopathy treated with inhaled steroid therapy. J Small Anim Pract. 2016;57:537-542.
Cohn LA, DeClue AE, Reinero CR. Endocrine and immunologic effects of inhaled fluticasone propionate in healthy dogs. J Vet Intern Med. 2008;22:37-43.
Grobman M, Reinero C. Investigation of Neurokinin-1 receptor antagonism as a novel treatment for chronic bronchitis in dogs. J Vet Intern Med. 2016;30:847-852.
Durant AM, Sura P, Rohrbach B, Bohling MW. Use of nitinol stents for end-stage tracheal collapse in dogs. Vet Surg. 2012;41:807-817.
Moritz A, Schneider M, Bauer N. Management of advanced tracheal collapse in dogs using intraluminal self-expanding biliary wallstents. J Vet Intern Med. 2004;18:31-42.
Corcoran BM, King LG, Schwarz T, Hammond G, Sullivan M. Further characterisation of the clinical features of chronic pulmonary disease in West Highland white terriers. Vet Rec. 2011;168:355.
Heikkila-Laurila HP, Rajamaki MM. Idiopathic pulmonary fibrosis in West Highland white terriers. Vet Clin North Am Small Anim Pract. 2014;44:129-142.
Silverstein D, Greene C, Gregory C, Lucas S, Quandt J. Pulmonary alveolar proteinosis in a dog. J Vet Intern Med. 2000;14:546-551.
Weissenbacher-Lang C, Fuchs-Baumgartinger A. Guija-De-Arespacochaga a, et al. Pneumocystosis in dogs: meta-analysis of 43 published cases including clinical signs, diagnostic procedures, and treatment. J Vet Diagn Invest. 2018;30:26-35.
Dupre G, Heidenreich D. Brachycephalic syndrome. Vet Clin North Am Small Anim Pract. 2016;46:691-707.
Liu NC, Oechtering GU, Adams VJ, Kalmar L, Sargan DR, Ladlow JF. Outcomes and prognostic factors of surgical treatments for brachycephalic obstructive airway syndrome in 3 breeds. Vet Surg. 2017;46:271-280.
Oechtering GU, Pohl S, Schlueter C, Schuenemann R. A novel approach to brachycephalic syndrome. 2. Laser-assisted turbinectomy (LATE). Vet Surg. 2016;45:173-181.
Poncet CM, Dupre GP, Freiche VG, Bouvy BM. Long-term results of upper respiratory syndrome surgery and gastrointestinal tract medical treatment in 51 brachycephalic dogs. J Small Anim Pract. 2006;47:137-142.
Schuenemann R, Pohl S, Oechtering GU. A novel approach to brachycephalic syndrome. 3. Isolated laser-assisted turbinectomy of caudal aberrant turbinates (CAT LATE). Vet Surg. 2017;46:32-38.
Nafe LA, Grobman ME, Masseau I, Reinero CR. Aspiration-related respiratory disorders in dogs. J Am Vet Med Assoc. 2018;253:292-300.
Goggs R, Benigni L, Fuentes VL, Chan DL. Pulmonary thromboembolism. J Vet Emerg Crit Care (San Antonio, Tex: 2001. 2009;19:30-52.
Goggs R, Bacek L, Bianco D, Koenigshof A, Li RHL. Consensus on the rational use of antithrombotics in veterinary critical care (CURATIVE): domain 2-defining rational therapeutic usage. J Vet Emerg Crit Care (San Antonio, Tex: 2001. 2019;29:49-59.
Elsheikha HM, Holmes SA, Wright I, Morgan ER, Lacher DW. Recent advances in the epidemiology, clinical and diagnostic features, and control of canine cardio-pulmonary angiostrongylosis. Vet Res. 2014;45:92.
Pulido T, Zayas N, de Mendieta MA, Plascencia K, Escobar J. Medical therapies for pulmonary arterial hypertension. Heart Fail Rev. 2016;21:273-283.
Murphy LA, Russell N, Bianco D, Nakamura RK. Retrospective evaluation of pimobendan and sildenafil therapy for severe pulmonary hypertension due to lung disease and hypoxia in 28 dogs (2007-2013). Vet Med Sci. 2017;3:99-106.
Nakamura K, Yamasaki M, Ohta H, et al. Effects of sildenafil citrate on five dogs with Eisenmenger's syndrome. J Small Anim Pract. 2011;52:595-598.
Ueda Y, Johnson LR, Ontiveros ES, Visser LC, Gunther-Harrington CT, Stern JA. Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension. Sci Rep. 2019;9:6899.
Akabane R, Sato T, Sakatani A, Miyagawa Y, Tazaki H, Takemura N. Pharmacokinetics of single-dose sildenafil administered orally in clinically healthy dogs: effect of feeding and dose proportionality. J Vet Pharmacol Ther. 2018;41:457-462.
Yang HJ, Oh YI, Jeong JW, Song KH, Koo TS, Seo KW. Comparative single-dose pharmacokinetics of sildenafil after oral and rectal administration in healthy beagle dogs. BMC Vet Res. 2018;14:291.
Jaffey JA, Leach SB, Kong LR, Wiggen KE, Bender SB, Reinero CR. Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study. J Vet Cardiol. 2019;24:7-19.
Porciello F, Rishniw M, Ljungvall I, Ferasin L, Haggstrom J, Ohad DG. Sleeping and resting respiratory rates in dogs and cats with medically-controlled left-sided congestive heart failure. Vet J (London, England: 1997. 2016;207:164-168.
Rishniw M, Ljungvall I, Porciello F, Häggström J, Ohad DG. Sleeping respiratory rates in apparently healthy adult dogs. Res Vet Sci. 2012;93:965-969.
Klinger JR, Elliott G, Levine DJ, et al. Therapy for pulmonary arterial hypertension in adults 2018: update of the CHEST guideline and expert panel report. Chest. 2019;155(3):565-586.
Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493-2537.
Bonatti HJ, Harris T, Bauer T, et al. Transfemoral catheter thrombolysis and use of sildenafil in acute massive pulmonary embolism. J Cardiothorac Vasc Anesth. 2010;24:980-984.
Ganiere V, Feihl F, Tagan D. Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism. Intensive Care Med. 2006;32:452-454.
Lewis GD, Bloch KD, Semigran MJ. Pulmonary thromboembolism superimposed on a congenital ventricular septal defect in a 50-year-old man inhaled nitric oxide and sildenafil to the rescue. Cardiol Rev. 2004;12:188-190.
Tjostheim SS, Kellihan HB, Grint KA, Stepien RL. Effect of sildenafil and pimobendan on intracardiac infections in four dogs. J Vet Cardiol. 2019;23:96-103.
den Toom ML, Grinwis G, van Suylen RJ, et al. Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog. Acta Vet Scand. 2018;60:78.
Suzuki S, Fukushima R, Ishikawa T, et al. The effect of pimobendan on left atrial pressure in dogs with mitral valve regurgitation. J Vet Intern Med. 2011;25:1328-1333.
Chen EP, Bittner HB, Davis RD, et al. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. J Heart Lung Transplant. 1998;17:669-678.
Tanaka H, Tajimi K, Moritsune O, et al. Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertension. Crit Care Med. 1991;19:68-74.
Douschan P, Kovacs G, Foris V, et al. Imatinib for right heart failure in COPD. Pulm Circ. 2019;9:2045894018816974.
Sato H, Sugimura K, Miura M, et al. Beneficial effects of Imatinib in a patient with suspected pulmonary Veno-occlusive disease. Tohoku J Exp Med. 2019;247:69-73.
Kimura G, Kataoka M, Inami T, Fukuda K, Yoshino H, Satoh T. Sorafenib as a potential strategy for refractory pulmonary arterial hypertension. Pulm Pharmacol Ther. 2017;44:46-49.
Ghofrani HA, Morrell NW, Hoeper MM, et al. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. Am J Respir Crit Care Med. 2010;182:1171-1177.
Hoeper MM, Barst RJ, Bourge RC, et al. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation. 2013;127:1128-1138.
Arita S, Arita N, Hikasa Y. Therapeutic effect of low-dose imatinib on pulmonary arterial hypertension in dogs. Can Vet J. 2013;54:255-261.
Weatherald J, Chaumais MC, Montani D. Pulmonary arterial hypertension induced by tyrosine kinase inhibitors. Curr Opin Pulm Med. 2017;23:392-397.
Flynn KM, Kellihan HB, Trepanier LA. Plasma l-citrulline concentrations in l-arginine-supplemented healthy dogs. J Vet Cardiol. 2017;19:376-383.
Souza-Silva AR, Dias-Junior CA, Uzuelli JA, Moreno H Jr, Evora PR, Tanus-Santos JE. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. Eur J Pharmacol. 2005;524:126-131.
O'Grady MR, O'Sullivan ML. Dilated cardiomyopathy: an update. Vet Clin North Am Small Anim Pract. 2004;34:1187-1207.
Swimmer RA, Rozanski EA. Evaluation of the 6-minute walk test in pet dogs. J Vet Intern Med. 2011;25:405-406.
Lilja-Maula LI, Laurila HP, Syrja P, et al. Long-term outcome and use of 6-minute walk test in West Highland white terriers with idiopathic pulmonary fibrosis. J Vet Intern Med. 2014;28:379-385.
Schnyder M, Stebler K, Naucke TJ, Lorentz S, Deplazes P. Evaluation of a rapid device for serological in-clinic diagnosis of canine angiostrongylosis. Parasit Vectors. 2014;7:72.
Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-117.
Freeman LM, Rush JE, Farabaugh AE, Must A. Development and evaluation of a questionnaire for assessing health-related quality of life in dogs with cardiac disease. J Am Vet Med Assoc. 2005;226:1864-1868.
